| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Products registered through the WHO collaborative registration procedure | www.who.int/prequal | - Collaborative Registration | |||||||||||||||||||||||
2 | List Number 64, updated 12July 2021 | #ERROR! | marketing authorizations approved | |||||||||||||||||||||||
3 | u Notes and disclaimer | Update history | ||||||||||||||||||||||||
4 | ||||||||||||||||||||||||||
5 | WHO PQ number | Notes | Product | Prequalification holder | Country of registration | Region | Registration date | Registration number | Year of registration (added by RP) | |||||||||||||||||
6 | DI005 | Zinc sulfate (Diarrhoea) Tablet, Dispersible 20mg | Macleods Pharmaceuticals Ltd | Uganda | AFRO | 30/Aug/17 | 9918/27/17 | 2017 | DI | |||||||||||||||||
7 | DI005 | Zinc sulfate (Diarrhoea) Tablet, Dispersible 20mg | Macleods Pharmaceuticals Ltd | Malawi | AFRO | 26/Mar/18 | PMPB/PL280/44 | 2018 | DI | |||||||||||||||||
8 | DI005 | Zinc sulfate (Diarrhoea) Tablet, Dispersible 20mg | Macleods Pharmaceuticals Ltd | Tanzania | AFRO | 9/Nov/17 | TZ 17 H 0163 | 2017 | DI | |||||||||||||||||
9 | DI005 | Zinc sulfate (Diarrhoea) Tablet, Dispersible 20mg | Macleods Pharmaceuticals Ltd | Ethiopia | AFRO | 23/Jul/18 | 3850/NMR/2017 | 2018 | DI | |||||||||||||||||
10 | DI005 | Zinc sulfate (Diarrhoea) Tablet, Dispersible 20mg | Macleods Pharmaceuticals Ltd | Zambia | AFRO | 30/Nov/19 | No. 192/055 | 2019 | DI | |||||||||||||||||
11 | HA053 | Lamivudine Oral solution 10mg/ml | Cipla Ltd | Ukraine | EURO | 30/Aug/16 | UA/15456/01/01 | 2016 | HA | |||||||||||||||||
12 | HA153 | Lamivudine Film-coated tablets 150mg | Hetero Labs Ltd | Philippines | WPRO | 6/Jun/17 | DR-XY45930 | 2017 | HA | |||||||||||||||||
13 | HA155 | Nevirapine Tablets 200mg | Hetero Labs Ltd | Philippines | WPRO | 23/May/17 | DR-XY45905 | 2017 | HA | |||||||||||||||||
14 | HA200 | Nevirapine Oral suspension 50mg/5ml | Cipla Ltd | Ukraine | EURO | 11/Aug/16 | UA/15388/01/01 | 2016 | HA | |||||||||||||||||
15 | HA200 | Nevirapine Oral suspension 50mg/5ml | Cipla Ltd | Zambia | AFRO | 8/Dec/20 | 099/018 | 2020 | HA | |||||||||||||||||
16 | HA268 | 2 | Nevirapine Tablets 200mg | Strides Shasun Ltd | Cameroon | AFRO | 20/Jan/17 | 4930117 | 2017 | HA | ||||||||||||||||
17 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | CARICOM | AMERICAS | 29/Jun/17 | CRS/052017/HA007 | 2017 | HA | |||||||||||||||||
18 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | DRC | AFRO | 3/Jun/17 | N°MS.1253/10/05/0614/0221/2017 | 2017 | HA | |||||||||||||||||
19 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | Tanzania | AFRO | 21/Nov/16 | TAN07, 112 J05A STR | 2016 | HA | |||||||||||||||||
20 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | Mozambique | AFRO | 31/Aug/17 | 2018-002073 | 2017 | HA | |||||||||||||||||
21 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | Senegal | AFRO | 23/Aug/17 | 8004 | 2017 | HA | |||||||||||||||||
22 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | Nigeria | AFRO | 20/Dec/17 | A4-6033 | 2017 | HA | |||||||||||||||||
23 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | Zambia | AFRO | 1/Feb/18 | 090/024 | 2018 | HA | |||||||||||||||||
24 | HA268 | Nevirapine Tablets 200mg | Strides Shasun Ltd | Burundi | AFRO | 20/Dec/19 | MSPLS-DPML-306N/2019 | 2019 | HA | |||||||||||||||||
25 | HA275 | Lamivudine + Nevirapine + Zidovudine Tablets 150mg + 200mg + 300mg | Hetero Labs Ltd | Namibia | AFRO | 6/Jun/13 | 13/20.2.8/0144 | 2013 | HA | |||||||||||||||||
26 | HA275 | Lamivudine + Nevirapine + Zidovudine Tablets 150mg + 200mg + 300mg | Hetero Labs Ltd | Philippines | WPRO | 6/Jun/17 | DR-XY45928 | 2017 | HA | |||||||||||||||||
27 | HA286 | Lamivudine/Zidovudine Tablet, Film-coated 150mg/300mg | Sun Pharmaceutical Industries Limited | Philippines | WPRO | 6/Aug/20 | DR-XY46999 | 2020 | HA | |||||||||||||||||
28 | HA291 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Strides Shasun Ltd | Nigeria | AFRO | 25/Nov/16 | B4-6680 | 2016 | HA | |||||||||||||||||
29 | HA291 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Strides Shasun Ltd | CARICOM | AMERICAS | 20/Apr/17 | CRS/022017/HA001 | 2017 | HA | |||||||||||||||||
30 | HA291 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Strides Shasun Ltd | Senegal | AFRO | 23/Aug/17 | 8003 | 2017 | HA | |||||||||||||||||
31 | HA291 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Strides Shasun Ltd | Zimbabwe | AFRO | 1/Mar/18 | 2018/7.13/5573 | 2018 | HA | |||||||||||||||||
32 | HA291 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Strides Shasun Ltd | Kyrgyzstan | EURO | 13/Feb/18 | KG 1.3.103.05562-2018 | 2018 | HA | |||||||||||||||||
33 | HA291 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Strides Shasun Ltd | Namibia | AFRO | 25/Jul/19 | 19/20.2.8/0120 | 2019 | HA | |||||||||||||||||
34 | HA291 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Strides Shasun Ltd | Burundi | AFRO | 20/Dec/19 | MSPLS-DPML-303N/2019 | 2019 | HA | |||||||||||||||||
35 | HA306 | Efavirenz Tablet, Film-coated 600mg | Sun Pharmaceutical Industries Limited | Philippines | WPRO | 6/Aug/20 | DR-XY47000 | 2020 | HA | |||||||||||||||||
36 | HA313 | Lamivudine + Stavudine Tablets 150mg + 30mg | Strides Shasun Ltd | Namibia | AFRO | 10/Aug/15 | 15/20.2.8/0168 | 2015 | HA | |||||||||||||||||
37 | HA352 | Efavirenz Tablet, Film-coated 600mg | Cipla Ltd | Zambia | AFRO | 9/Dec/20 | 099/099 | 2020 | HA | |||||||||||||||||
38 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Ghana | AFRO | 23/Jan/17 | FDB/GD.173-1003 | 2017 | HA | |||||||||||||||||
39 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Ukraine | EURO | 25/May/17 | UA/11464/01/01 | 2017 | HA | |||||||||||||||||
40 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | CARICOM | AMERICAS | 10/Jul/17 | CRS/052017/HA009 | 2017 | HA | |||||||||||||||||
41 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | DRC | AFRO | 3/Jun/17 | N°MS.1253/10/05/0614/0223/2017 | 2017 | HA | |||||||||||||||||
42 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Mozambique | AFRO | 31/Aug/17 | 4978 | 2017 | HA | |||||||||||||||||
43 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Senegal | AFRO | 23/Aug/17 | 8001 | 2017 | HA | |||||||||||||||||
44 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Zambia | AFRO | 1/Feb/18 | 090/023 | 2018 | HA | |||||||||||||||||
45 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Zimbabwe | AFRO | 1/Mar/18 | 2018/7.13/5577 | 2018 | HA | |||||||||||||||||
46 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Tanzania | AFRO | 11/Sep/18 | (blank) | 2018 | HA | |||||||||||||||||
47 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Nigeria | AFRO | 18/Nov/19 | A4-0031 | 2019 | HA | |||||||||||||||||
48 | HA389 | Efavirenz Tablets 200mg | Strides Shasun Ltd | Burundi | AFRO | 20/Dec/19 | MSPLS-DPML-307N/2019 | 2019 | HA | |||||||||||||||||
49 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Ghana | AFRO | 23/Jan/17 | FDB/GD.173-1004 | 2017 | HA | |||||||||||||||||
50 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Ukraine | EURO | 25/May/17 | UA/11464/01/02 | 2017 | HA | |||||||||||||||||
51 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | CARICOM | AMERICAS | 10/Jul/17 | CRS/052017/HA008 | 2017 | HA | |||||||||||||||||
52 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | DRC | AFRO | 3/Jun/17 | N°MS.1253/10/05/0614/0224/2017 | 2017 | HA | |||||||||||||||||
53 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Mozambique | AFRO | 3/Aug/17 | 5061 | 2017 | HA | |||||||||||||||||
54 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Senegal | AFRO | 23/Aug/17 | 8001 Bis | 2017 | HA | |||||||||||||||||
55 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Nigeria | AFRO | 20/Dec/17 | A4-0030 | 2017 | HA | |||||||||||||||||
56 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Cameroon | AFRO | 20/Dec/17 | 4940803 | 2017 | HA | |||||||||||||||||
57 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Zimbabwe | AFRO | 1/Mar/18 | 2018/7.13/5576 | 2018 | HA | |||||||||||||||||
58 | HA390 | Efavirenz Tablets 600mg | Strides Shasun Ltd | Burundi | AFRO | 20/Dec/19 | MSPLS-DPML-308N/2019 | 2019 | HA | |||||||||||||||||
59 | HA399 | Efavirenz Tablets 600mg | Hetero Labs Ltd | Ghana | AFRO | 7/Jul/14 | FDB/SD.143-6055 | 2014 | HA | |||||||||||||||||
60 | HA399 | Efavirenz Tablets 600mg | Hetero Labs Ltd | Cameroon | AFRO | 9/Jul/14 | 6621401 | 2014 | HA | |||||||||||||||||
61 | HA399 | Efavirenz Tablets 600mg | Hetero Labs Ltd | Philippines | WPRO | 23/May/17 | DR-XY45901 | 2017 | HA | |||||||||||||||||
62 | HA401 | Tenofovir disoproxil fumarate Tablet, Film-coated 300mg | Cipla Ltd | Zambia | AFRO | 9/Dec/20 | 099/101 | 2020 | HA | |||||||||||||||||
63 | HA417 | Emtricitabine/Tenofovir disoproxil fumarate Tablet, Film-coated 200mg/300mg | Hetero Labs Ltd | Philippines | WPRO | 13/May/20 | DR-XY46882 | 2020 | HA | |||||||||||||||||
64 | HA424 | Lamivudine Tablets 150mg | Macleods Pharmaceuticals Ltd | Nigeria | AFRO | 22/Oct/15 | B4-5671 | 2015 | HA | |||||||||||||||||
65 | HA424 | Lamivudine Tablets 150mg | Macleods Pharmaceuticals Ltd | Malawi | AFRO | 24/May/16 | PMPB/PL280/32 | 2016 | HA | |||||||||||||||||
66 | HA424 | Lamivudine Tablets 150mg | Macleods Pharmaceuticals Ltd | Ethiopia | AFRO | 16/Feb/17 | 2903/2577/NMR/2016 | 2017 | HA | |||||||||||||||||
67 | HA424 | Lamivudine Tablets 150mg | Macleods Pharmaceuticals Ltd | Burundi | AFRO | 28/Sep/17 | MSPLS-DPML010N/2017 | 2017 | HA | |||||||||||||||||
68 | HA424 | Lamivudine Tablets 150mg | Macleods Pharmaceuticals Ltd | Uganda | AFRO | 22/Jun/17 | 9862/30/17 | 2017 | HA | |||||||||||||||||
69 | HA436 | Abacavir (as sulfate) + Lamivudine + Zidovudine Tablets 60mg + 30mg + 60mg | Mylan Laboratories Limited | Zimbabwe | AFRO | 6/Feb/13 | 2013/7.13/4762 | 2013 | HA | |||||||||||||||||
70 | HA439 | Emtricitabine/Tenofovir disoproxil fumarate Tablet, Film-coated 200mg/300mg | Cipla Ltd | Zambia | AFRO | 16/Dec/20 | 099/177 | 2020 | HA | |||||||||||||||||
71 | HA448 | Lamivudine + Tenofovir disoproxil fumarate Tablets 300mg + 300mg | Hetero Labs Ltd | Ghana | AFRO | 1/Oct/13 | FDB/GD.133-9038 | 2013 | HA | |||||||||||||||||
72 | HA448 | Lamivudine + Tenofovir disoproxil fumarate Tablets 300mg + 300mg | Hetero Labs Ltd | Philippines | WPRO | 6/Jun/17 | DR-XY45929 | 2017 | HA | |||||||||||||||||
73 | HA457 | Zidovudine Tablets 300mg | Hetero Labs Ltd | Philippines | WPRO | 14/Sep/17 | DRP-7341 | 2017 | HA | |||||||||||||||||
74 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | Ukraine | EURO | 29/Dec/14 | UA/14139/01/01 | 2014 | HA | |||||||||||||||||
75 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | Nigeria | AFRO | 22/Oct/15 | B4-5678 | 2015 | HA | |||||||||||||||||
76 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | Uganda | AFRO | 9/Mar/16 | 9254/30/16 | 2016 | HA | |||||||||||||||||
77 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | Malawi | AFRO | 24/May/16 | PMPB/PL280/26 | 2016 | HA | |||||||||||||||||
78 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | Burundi | AFRO | 28/Sep/17 | MSPLS-DPML012N/2017 | 2017 | HA | |||||||||||||||||
79 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | Eritrea | AFRO | 28/Dec/18 | NMFA/GM/18/00006 | 2018 | HA | |||||||||||||||||
80 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | CARICOM | AMERICAS | 18/Apr/19 | (blank) | 2019 | HA | |||||||||||||||||
81 | HA459 | Lamivudine + Zidovudine Tablets 150mg + 300mg | Macleods Pharmaceuticals Ltd | Ukraine | EURO | 13/Apr/20 | UA/14139/01/01. | 2020 | HA | |||||||||||||||||
82 | HA465 | Nevirapine Tablets 200mg | Macleods Pharmaceuticals Ltd | Nigeria | AFRO | 22/Oct/15 | B4-5676 | 2015 | HA | |||||||||||||||||
83 | HA465 | Nevirapine Tablets 200mg | Macleods Pharmaceuticals Ltd | Uganda | AFRO | 9/Mar/16 | 9244/30/16 | 2016 | HA | |||||||||||||||||
84 | HA465 | Nevirapine Tablets 200mg | Macleods Pharmaceuticals Ltd | Malawi | AFRO | 24/May/16 | PMPB/PL280/28 | 2016 | HA | |||||||||||||||||
85 | HA465 | Nevirapine Tablets 200mg | Macleods Pharmaceuticals Ltd | Ethiopia | AFRO | 8/May/17 | 3079/3428/NMR72017 | 2017 | HA | |||||||||||||||||
86 | HA465 | Nevirapine Tablets 200mg | Macleods Pharmaceuticals Ltd | Mozambique | AFRO | 3/Aug/17 | 5055 | 2017 | HA | |||||||||||||||||
87 | HA465 | Nevirapine Tablets 200mg | Macleods Pharmaceuticals Ltd | Burundi | AFRO | 28/Sep/17 | MSPLS-DPML013N/2017 | 2017 | HA | |||||||||||||||||
88 | HA466 | Efavirenz/Lamivudine/Tenofovir disoproxil fumarate | Mylan Laboratories Limited | Mozambique | AFRO | 31/Aug/17 | J5096 | 2017 | HA | |||||||||||||||||
89 | HA466 | Efavirenz/Lamivudine/Tenofovir disoproxil fumarate | Mylan Laboratories Limited | CARICOM | AMERICAS | 4/Aug/17 | CRS/062017/HA010 | 2017 | HA | |||||||||||||||||
90 | HA473 | Didanosine Delayed release capsules 250mg | Mylan Laboratories Limited | Zimbabwe | AFRO | 6/Feb/13 | 2013/7.13/4763 | 2013 | HA | |||||||||||||||||
91 | HA486 | Zidovudine Oral solution 50mg/5ml | Hetero Labs Ltd | Philippines | WPRO | 6/Jun/17 | DR-XY45927 | 2017 | HA | |||||||||||||||||
92 | HA486 | Zidovudine Oral solution 50mg/5ml | Hetero Labs Ltd | Ukraine | EURO | 23/Apr/20 | UA/17965/01/01. | 2020 | HA | |||||||||||||||||
93 | HA492 | Lopinavir + Ritonavir Tablets 200mg + 50mg | Hetero Labs Ltd | Namibia | AFRO | 6/Jun/13 | 13/20.2.8/0145 | 2013 | HA | |||||||||||||||||
94 | HA492 | Lopinavir + Ritonavir Tablets 200mg + 50mg | Hetero Labs Ltd | Nigeria | AFRO | 19/Sep/13 | B4-0455 | 2013 | HA | |||||||||||||||||
95 | HA492 | Lopinavir + Ritonavir Tablets 200mg + 50mg | Hetero Labs Ltd | Ghana | AFRO | 1/Oct/13 | FDB/GD.133-9034 | 2013 | HA | |||||||||||||||||
96 | HA492 | Lopinavir + Ritonavir Tablets 200mg + 50mg | Hetero Labs Ltd | Zimbabwe | AFRO | 11/Mar/14 | 2014/7.13/4864 | 2014 | HA | |||||||||||||||||
97 | HA492 | Lopinavir + Ritonavir Tablets 200mg + 50mg | Hetero Labs Ltd | Philippines | WPRO | 23/May/17 | DR-XY45903 | 2017 | HA | |||||||||||||||||
98 | HA493 | Abacavir (as sulfate) Oral solution 20mg/ml | Hetero Labs Ltd | Burkina Faso | AFRO | 15/Apr/15 | 0724720154G000000 | 2015 | HA | |||||||||||||||||
99 | HA493 | Abacavir (as sulfate) Oral solution 20mg/ml | Hetero Labs Ltd | Philippines | WPRO | 16/Jun/17 | DR-XY45934 | 2017 | HA | |||||||||||||||||
100 | HA493 | Abacavir (as sulfate) Oral solution 20mg/ml | Hetero Labs Ltd | Ukraine | EURO | 23/Apr/20 | UA/14957/02/01. | 2020 | HA |